IL6 and cancer: In addition, this long term chemotherapy can also enhance proliferation of cancer stem cells (CSCs) that secrete more than 100 times more IL-6 than parent cells [13], which induces up-regulation of NF-κB to support anti-apoptosis, reducing anti-tumor efficacy [14].